Scientific Advisory Board

Scientific Advisory Board at PL BioScience

Guiding our ELAREM™ technology to a cutting-edge innovator of regenerative therapies

The Scientific Advisory Board plays a crucial role in the shaping of our R&D activities. With our ELAREM™ Human Platelet Lysates, we follow the mission to accelerate the multiple developments in the treatment of life-threatening diseases. For that reason, we are glad to be supported by leading biotech experts from the fields of cell therapy and regenerative medicine.

Consequently, we are convinced that the Scientific Advisory Board’s academic, clinical and industrial insights combined with our specialist expertise help us answer the far-reaching scientific questions of tomorrow.

Members of the Scientific Advisory Board

We are glad to introduce the first member of our Scientific Advisory Board

“We warmly welcome Lindsay Davies as the first member of the Scientific Advisory Board. The entire team looks forward to exchanging on cutting-edge ideas. Without doubt, Lindsay’s valuable clinical experience in the cell therapy field helps us promote the development of regenerative therapies for patients in need.“

Dr. Hatim Hemeda CEO of PL BioScience

Dr. Hatim Hemeda, CEO

Scientific Advisory Board - Lindsay Davies

+ - Lindsay Davies, PhD

CEO and Founder of CellTherEx

Lindsay is the CEO and Founder of CellTherEx, a life science consultancy company, helping academics to translate their research to the clinic. She brings more than 15 years of experience in the fields of cell therapy and regenerative medicine. In short, she held international positions at Karolinska Institute, Cardiff University and Finnish Red Cross Blood Service.

Uniting academic and industrial insights

During her career, Lindsay has gained broad expert knowledge in preclinical research, clinical trial design and product development within cell therapy and regenerative medicine. Thus, she has built a wide-ranging network in the cell and gene therapy community.

Additionally, she contributes her expert knowledge as a member of numerous Scientific Advisory Boards including European Tissue Repair Society. Next to that, she is a member of the Commercialisation Committee for the International Society of Cell and Gene Therapy (ISCT).

Renowned scientific achievements

During her career, Lindsay has been presented with several awards. Beside that, she is the named inventor on numerous granted patents. Also, she has extensively published in the field of regenerative medicine. Her publications focus on the use of advanced therapies for immune mediated disorders including Graft versus Host Disease and Type I Diabetes.

Track record

Lindsay has a great success story in receiving external grant funding, clinical trial applications, GMP manufacturing as well as mentorship for spin-outs and SMEs. All in all, with the aim of supporting the transition from lab to patients.

Any questions?
close slider

Any questions?

Please contact us:

+49 (0) 241 95719-100